Key facts
- ClearLeaf’s last known valuation is $16.5M (Apr 2025).
- It has raised $9.8M.
- Notable investors include MassChallenge, Village Capital, gBETA, StartLife, Fresh Field Catalyst Accelerator — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for ClearLeaf
- ·The full record, as it builds
Funding rounds
No funding rounds for ClearLeaf are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ClearLeaf
Developer of a non-toxic contact action liquid emulsion designed to manage the impacts of harmful pests without impacting the environment or human health. The company creates sustainable alternatives to the toxic agrochemicals used in agriculture while maintaining natural balances on the farm and protecting consumers, enabling farmers with efficiency and on a large scale to positively affect the world and to improve worker safety conditions on the farm through the creation of alternative crop inputs.
- Sector
- Materials and Resources
- HQ
- San Nicolás, Costa Rica
- Founded
- 2017
- Employees
- 20
- Website
- clearagro.com/
- Ownership
- Privately Held (backing)
ClearLeaf doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ClearLeaf shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ClearLeaf in its N-PORT filings yet. We sweep new filings monthly.